Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document
 
Table of Contents

                         
        Percentage of
    Number of
  Common Stock
    Shares
  Beneficially Owned
    Beneficially
  Prior to
  After
Beneficial Owner
  Owned   Offering   Offering
 
Directors and Executive Officers:
                       
Gary D. Tollefson, M.D., Ph.D.(7)
    737,549       3.8 %     2.9 %
Anthony A. McKinney(8)
    182,703       1.0       *  
Graham K. Cooper(9)
    262,944       1.4       1.0  
Eduardo Dunayevich, M.D. 
                 
Ronald P. Landbloom, M.D. 
                 
Lynne Rollins(10)
    10,000       *       *  
Eckard Weber, M.D. 
    650,000       3.4       2.6  
Louis C. Bock
                   
Brian H. Dovey(1)
    4,023,807       21.3       16.2  
Joseph S. Lacob(2)
    2,674,588       14.2       10.8  
Michael F. Powell, Ph.D.(3)
    2,822,854       15.0       11.4  
Daniel K. Turner III(5)
    1,398,712       7.4       5.6  
Executive officers and directors as a group (14 persons)(11)
    12,974,344       64.8       49.8  
 
* Represents beneficial ownership of less than one percent of our outstanding common stock.
 
(1) Includes 3,930,948 shares of common stock held by Domain Partners V, L.P. and 92,859 shares of common stock held by DP V Associates, L.P. The voting and disposition of the shares held by Domain Partners V, L.P. and DP V Associates, L.P. is determined by the managing members of One Palmer Square Associates V, L.L.C., the general partner of Domain Partners V, L.P. and DP V Associates, L.P. Dr. Weber, the chairman of our board of directors, is an employee of Domain Associates, L.L.C., the manager of Domain Partners V, L.P. and DP V Associates, L.P. Dr. Weber has no ownership interest, or voting or investment power with respect to the shares held by Domain Partners V, L.P. and DP V Associates, L.P. Mr. Dovey, a member of our board of directors, is a managing member of One Palmer Square Associates V, L.L.C. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
 
(2) Includes 2,575,573 shares beneficially held by Kleiner Perkins Caufield & Byers X-A, L.P., 72,642 shares beneficially held by Kleiner Perkins Caufield & Byers X-B, L.P. and 26,373 shares beneficially held by Mr. Lacob. Excludes, in the case of Mr. Lacob, 1,089,219 shares held by other entities affiliated with Kleiner Perkins Caufield & Byers as to which Mr. Lacob does not have voting or dispositive power. Lacob Ventures, LLC, whose manager is Mr. Lacob, a member of our board of directors, is a manager of the general partners of the Kleiner Perkins Caufield & Byers funds and has shared voting and investment power over these shares. Shares are held for convenience in the name of “KPCB Holdings, Inc. as nominee” for the account of entities affiliated with Kleiner Perkins Caufield & Byers and others. KPCB Holdings, Inc. has no voting, dispositive or pecuniary interest in any such shares. Mr. Lacob disclaims beneficial ownership of any of the shares held by the aforementioned entities, except to the extent of his pecuniary interest therein.
 
(3) Includes 2,329,551 shares held by Sofinnova Venture Partners VI, L.P., 461,548 shares held by Sofinnova Venture Partners VI GmbH & Co. KG. and 31,755 shares held by Sofinnova Venture Affiliates VI, L.P. The voting and disposition of the shares held by Sofinnova Venture Partners VI, L.P. and Sofinnova Venture Affiliates VI, L.P. are determined by Sofinnova Management VI, L.L.C., which is the general partner of each. The voting and disposition of the shares held by Sofinnova Venture Partners VI GmbH & Co. KG. are determined by Sofinnova Management VI, L.L.C., which is the managing limited partner of Sofinnova Venture Partners VI GmbH & Co. KG. Dr. Powell, a member of our board of directors, is a

(footnotes continued on following page)

114